Physician

Kent K. Huston, M.D.

According to 2025 Medicare claims, Kent Huston, M.D. (NPI: 1194739227) practices rheumatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Clay, MO. This provider's primary affiliated billing organization is KANSAS CITY PHYSICIAN PARTNERS INC (NPI: 1831531466; TIN: 463233706) and primary practice location at 64151-5102. Huston is affiliated with the Aledade 38 KS CHC MSSP Enhanced (ACO ID: A4546) and Centrus Health of Kansas LLC (ACO ID: A5305), participating under the MSSP model.

Huston's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 732 traditional Medicare patients, billed 225,528 HCPCS/CPT codes, and received $2,125,094 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,609 prescription claims across 755 beneficiaries totaling $2,204,077 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2015 DME data shows 11 claims. Open Payments data shows 1 records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,347,388 to $2,125,094. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $585,690 to $2,204,077. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	793	122,443	$1,347,388
2016	756	109,747	$1,171,238
2017	785	88,920	$1,110,999
2018	733	62,613	$835,483
2019	754	78,748	$995,683
2020	714	121,164	$1,416,677
2021	737	131,677	$1,550,911
2022	724	159,028	$1,538,737
2023	698	198,099	$1,825,500
2024	732	225,528	$2,125,094

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	551	3,604	$585,690
2016	599	4,147	$719,533
2017	573	4,204	$852,849
2018	636	4,580	$1,081,536
2019	643	4,579	$1,081,765
2020	660	4,964	$1,580,469
2021	668	4,765	$1,801,600
2022	695	4,933	$1,788,254
2023	699	5,202	$2,483,145
2024	755	5,609	$2,204,077

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$1,117
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	460	898	$83
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	401	566	$12
36415	Insertion of needle into vein for collection of blood sample	455	1,117	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	404	979	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	430	1,005	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	52	1,568	$458,201
Enbrel	Etanercept	16	896	$230,104
Cosentyx Sensoready Pen	Secukinumab	17	756	$204,710
Enbrel Sureclick	Etanercept	17	532	$147,791
Cimzia (2 Pack)	Certolizumab Pegol	22	616	$126,701

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$1,304	Consortium of Independent Immunology Clinics, LLC

Explore More Providers

FAQ

What Medicare data is available for Kent K. Huston, M.D.?

Tedicare shows public-source Medicare data for Kent K. Huston, M.D. (NPI 1194739227), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kent K. Huston, M.D. have ACO affiliation data?

Kent K. Huston, M.D. is shown with ACO affiliation data for Aledade 38 KS CHC MSSP Enhanced (MSSP, ACO ID A4546) and Centrus Health of Kansas LLC (MSSP, ACO ID A5305).

What billing organization is linked to Kent K. Huston, M.D.?

Kent K. Huston, M.D. is linked to KANSAS CITY PHYSICIAN PARTNERS INC (billing NPI 1831531466) in the available physician profile data.

Does Kent K. Huston, M.D. have Open Payments data?

Kent K. Huston, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.